Pfizer’s Kindler elected PhRMA chairman
pharmafile | March 22, 2010 | Appointment | Research and Development, Sales and Marketing | PhRMA, appointment, research and development, sales and marketing
Jeffrey Kindler, chairman and chief executive of Pfizer, has been elected chairman of PhRMA, succeeding AstraZeneca’s chief executive David Brennan in the role.
“I am excited to lead this organisation during such a dynamic time for our nation’s healthcare system,” Kindler said. “The biopharmaceutical industry can be a catalyst for change by creating a future with good jobs and good health in the US.”
“We aim to be a leading voice for improving everyone’s ability to have reliable and affordable health care.”
The US industry association has also elected Sanofi-Aventis chief executive Chris Viehbacher as chairman-elect of the board of directors and Lilly chief executive John Lechleiter as board treasurer.
Meanwhile, PhRMA president and chief executive Billy Tauzin will be stepping down at the end of June after five years of heading up the association, but plans to continue in a consultancy role.
Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …






